BCL2L1 and neoplasm: We found that lncRNA MEG3 appeared to function as a tumor suppressor by regulating the p53 and Bcl-xl-induced mitochondrial apoptosis pathway, and showed that its increased expression was positively correlated with the sensitivity of LAD patients to cisplatin treatment.